Pharma Mar, S.A. (PHM.MC)
EUR 76.95
(0.59%)
EUR 76.95
(0.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 158.15 Million | 196.34 Million | 229.83 Million | 269.96 Million | 85.81 Million | 162.16 Million |
| Cost of Revenue | 9.61 Million | 13.63 Million | 16.43 Million | 13.71 Million | 5.22 Million | 35.86 Million |
| Gross Profit | 148.54 Million | 182.7 Million | 213.39 Million | 256.24 Million | 80.59 Million | 126.29 Million |
| Operating Expenses | 152.36 Million | 138.26 Million | 121.04 Million | 100.03 Million | 98.06 Million | 140.44 Million |
| Selling, General and Administrative Expenses | 41.8 Million | 43.24 Million | 39.73 Million | 35.77 Million | 37.81 Million | 59.25 Million |
| Research and Development Expenses | 99.3 Million | 83.44 Million | 72.17 Million | 53.79 Million | 50.64 Million | 74.01 Million |
| Other Expenses | 11.26 Million | 11.57 Million | 9.13 Million | 10.46 Million | 9.6 Million | 7.18 Million |
| Cost and Expenses | 161.98 Million | 151.9 Million | 137.48 Million | 113.75 Million | 103.29 Million | 176.31 Million |
| Operating Income | -3.82 Million | 44.07 Million | 92.44 Million | 155.94 Million | -17.47 Million | -14.07 Million |
| Interest Expense | 2.41 Million | 2.37 Million | 3.37 Million | 3.12 Million | 3.88 Million | 4.7 Million |
| Income Tax Expense | -4.76 Million | -5.56 Million | 2.27 Million | 8.34 Million | -12.47 Million | -2.49 Million |
| Earnings before Tax | -3.62 Million | 43.79 Million | 95.12 Million | 145.6 Million | -21.65 Million | -18.7 Million |
| Net Income | 1.13 Million | 49.35 Million | 92.85 Million | 137.26 Million | -9.18 Million | -5.53 Million |
| Earnings Per Share Basic | 0.06 | 2.73 | 5.14 | 7.50 | -0.50 | -0.30 |
| Earnings Per Share Diluted | 0.06 | 2.73 | 5.13 | 7.49 | -0.50 | -0.30 |
| Weighted Average Shares Outstanding | 17.9 Million | 18.05 Million | 18.07 Million | 18.29 Million | 18.43 Million | 18.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 17.91 Million | 18.06 Million | 18.08 Million | 18.32 Million | 18.43 Million | 18.41 Million |
| Gross Margin | 0.94 | 0.93 | 0.93 | 0.95 | 0.94 | 0.78 |
| EBIT Margin | 0.03 | 0.28 | 0.45 | 0.58 | -0.13 | -0.04 |
| Profit Margin | 0.01 | 0.25 | 0.40 | 0.51 | -0.11 | -0.03 |
| EBITDA | 4.54 Million | 52.06 Million | 104.08 Million | 155.94 Million | -11.71 Million | -9.47 Million |
| Earnings Before Tax Margin | -0.02 | 0.22 | 0.40 | 0.58 | -0.20 | -0.09 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 45.65 Million | 42.87 Million | 37.96 Million | 158.15 Million | 40.51 Million | 37.45 Million |
| Cost of Revenue | 2 Million | 3.09 Million | 1.76 Million | 13.29 Million | 2.45 Million | 3.14 Million |
| Gross Profit | 43.64 Million | 39.77 Million | 36.2 Million | 144.86 Million | 38.06 Million | 34.3 Million |
| Operating Expenses | 38.18 Million | 40.5 Million | 40.53 Million | 150.21 Million | 43.23 Million | 35 Million |
| Selling, General and Administrative Expenses | 10.68 Million | 12.29 Million | 10.96 Million | - | 11.41 Million | 8.89 Million |
| Research and Development Expenses | 24.71 Million | 24.07 Million | 27.19 Million | - | 28.98 Million | 23.67 Million |
| Other Expenses | 2.79 Million | -4.13 Million | -2.97 Million | -12.78 Million | -2.84 Million | -3.09 Million |
| Cost and Expenses | 40.19 Million | 43.6 Million | 42.29 Million | 163.5 Million | 45.68 Million | 38.15 Million |
| Operating Income | 5.48 Million | -730 Thousand | -4.29 Million | -5.35 Million | -5.17 Million | -184 Thousand |
| Interest Expense | - | - | - | 2.41 Million | 1.35 Million | - |
| Income Tax Expense | -18 Thousand | 87 Thousand | -5.07 Million | -4.76 Million | 346 Thousand | 49 Thousand |
| Earnings before Tax | 3.88 Million | 1.32 Million | -2.77 Million | -3.62 Million | -6.47 Million | 1.57 Million |
| Net Income | 3.9 Million | 1.23 Million | 2.3 Million | 1.13 Million | -6.81 Million | 1.52 Million |
| Earnings Per Share Basic | 0.22 | 0.07 | 0.13 | - | -0.39 | 0.08 |
| Earnings Per Share Diluted | 0.22 | 0.07 | 0.13 | - | -0.39 | 0.08 |
| Weighted Average Shares Outstanding | 17.63 Million | 17.63 Million | 17.5 Million | 17.9 Million | 17.63 Million | 17.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 17.63 Million | 17.63 Million | 17.5 Million | 17.91 Million | 17.63 Million | 17.97 Million |
| Gross Margin | 0.96 | 0.93 | 0.95 | 0.92 | 0.94 | 0.92 |
| EBIT Margin | 0.15 | 0.02 | -0.07 | - | -0.09 | 0.01 |
| Profit Margin | 0.09 | 0.03 | 0.06 | 0.01 | -0.17 | 0.04 |
| EBITDA | 7 Million | 825 Thousand | -2.81 Million | - | -3.67 Million | 469 Thousand |
| Earnings Before Tax Margin | 0.12 | -0.02 | -0.11 | -0.03 | -0.13 | -0.00 |
2991
WEED
3313
1980
PRO
CHK